$CLDX Recent Headlines Stock leaders flex muscles 1:58

New Post Public Reply Private Reply Replies (0) Message Board

Mar 3, 2014 at 11:49 AM

$CLDX Recent Headlines

Stock leaders flex muscles 1:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 11:28 a.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 11:23 a.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 1:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 10:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 10:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 2:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 7:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 2:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 11:26 a.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 2:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 2:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 12:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 8:48 a.m. May 18, 2011 - MarketWatch.com

10-K: CELLDEX THERAPEUTICS, INC. 10 min ago - Edgar Online - (EDG = 10Q, 10K)
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due 10:32 a.m. Today - TheStreet.com
Celldex Therapeutics, Inc Discusses Q1 2014 Results (Webcast) 8:25 a.m. Today - Seeking Alpha
Eotaxin-1 Inhibition - The Next PD(L)-1 In Inflammatory Disease? 10:23 a.m. Feb. 21, 2014 - Seeking Alpha
Catalysts Drive These Stocks: Mara Goldstein 9:20 a.m. Feb. 21, 2014 - Seeking Alpha
Agenus: Acquisition Of 4-Antibody Is A Transformational Move 1:28 p.m. Feb. 20, 2014 - Seeking Alpha
Celldex Therapeutics Inc. (CLDX): Today's Featured Health Care Laggard 5:01 p.m. Feb. 13, 2014 - TheStreet.com
Use Options For A Chance To Buy CLDX At A 62% Discount 11:42 a.m. Feb. 13, 2014 - TheStreet.com
Do Away With The Pill-A-Day Biotech Model: Steve Brozak 2:05 p.m. Feb. 7, 2014 - Seeking Alpha
Combination Therapies: Where Immuno-Oncology Is Headed And How To Invest 8:55 a.m. Feb. 6, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 11:09 a.m. Jan. 25, 2014 - Seeking Alpha
First Week Of March 22nd Options Trading For Celldex Therapeutics (CLDX) 1:20 p.m. Jan. 22, 2014 - TheStreet.com
Cramer's Mad Money - 10 Trends Moving Stocks (1/21/14) 6:17 a.m. Jan. 22, 2014 - Seeking Alpha
Sell Watch: Zeltiq Has Become Over-Speculated 9:20 a.m. Jan. 21, 2014 - Seeking Alpha
Use Options For A Chance To Buy CLDX At A 58% Discount 11:43 a.m. Jan. 15, 2014 - TheStreet.com
Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
Best Biotech Ideas for 2014 1:35 p.m. Jan. 11, 2014 - Barrons.com
Celldex Therapeutics: Can an Orphan Program Create Larger Gains? 11:17 a.m. Jan. 8, 2014 - Wall St. Cheat Sheet
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More 7:46 a.m. Jan. 7, 2014 - 247WallSt.com

Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 8:03 a.m. Today - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 1:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 9:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 11:00 a.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 11:02 a.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 9:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 8:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 8:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 8:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 8:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 8:30 a.m. Dec. 10, 2013 - GlobeNewswire
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares 5:03 p.m. Dec. 9, 2013 - GlobeNewswire
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
Celldex Therapeutics Prices Public Offering of Common Stock 7:52 p.m. Dec. 4, 2013 - GlobeNewswire
Celldex Therapeutics Announces Proposed Public Offering of Common Stock 4:05 p.m. Dec. 3, 2013 - GlobeNewswire
Celldex Therapeutics Initiates METRIC, an Accelerated Approval Study of Glembatumumab Vedotin in Patients with Triple Negative Breast Cancer 7:00 a.m. Dec. 2, 2013 - GlobeNewswire
Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST 8:03 a.m. Nov. 27, 2013 - GlobeNewswire
Critical Alerts For Google, Philip Morris, Lockheed Martin, Celldex Therapeutics, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Nov. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa Welcomes Global Art Fair October 2026

Tampa Steps into the Global Art Scene Get this, Tampa is gearing up for its slice of the global art pie. Come October 2026, the Tampa Convention Center will transform into a bustling hub of creativity and culture. With over 300 artists slated to pour in from every corner of the globe, this isn't just any old art fair—it's Art Fair Tampa, and it's promising to be a...

Hemp Gift Guide Showcases Calm and Rest with CBD

Digging Into Holiday Wellness Gifts In this age where peace can feel as elusive as a pot of gold, gifting something that whispers serenity and comfort has its charm. Enter Rare Cannabinoid Company, a Hawaii-based brand, weaving from their cannabinoid blend a holiday gift guide designed to infuse calm into the season's chaos. Now, that's something. A Unique Take on Holiday...

Akash to Leverage Solana for AI Boom

By Dominic Sanders Updated Nov 2, 2026 Category News Views 105

Akash's Bold Move: Embracing Solana Never thought I'd see a day where Akash Network would toss its hat in with Solana. An unexpected power play, but not without reason. By moving their decentralized compute marketplace to Solana, they aim to leverage one of the slickest blockchain ecosystems around. It's like swapping a four-cylinder for a V8 – there's a potential for...

Exploring 'Deeper Prayer': A Journey with Apostle Paul

A Deep Dive into the Prayers of Apostle Paul Gary P. Rohrmayer's latest devotional takes believers on a unique journey, exploring the Apostle Paul's prayers across his missionary paths. But don't expect just another preacher prophesying from the pulpit. This is more like peeling back layers of history, bit by bit. 28 Days of Spiritual Insights Each day within the book...

Ericsson's Drone Tech and Share Buybacks: Impact & Insight

Ericsson's Latest Move into Drone Detection Brace yourself, folks! Ericsson is taking things to a whole new altitude, literally. They're bringing drone detection capabilities right to our mobile networks. It's like they're transforming our standard network towers into stealthy drone spotters. Think about a mobile network that not only keeps your calls from dropping but...

Tips to Pick the Right Primary Care Provider

Deciding on Your Healthcare Anchor The quest for the perfect primary care provider isn't just routine; it's a cornerstone to your overall healthcare strategy. When Healthcare Services Expert Sheila A. Berschauer from Moses Lake Community Health lays it all out in HelloNation, she pinpoints selecting a provider as one of the mightiest decisions in your health journey. This...

FirstEnergy Foundation Aims High with New Leadership

Changing the Guard at FirstEnergy Foundation For a company with a hefty footprint across the northeastern United States, FirstEnergy Corp. (NYSE: FE) seems to be diving deep into the philanthropic pool with its recent leadership shuffle. Don Rettig, an experienced figure in the world of corporate philanthropy, is taking the helm as Vice President and President of the...

Monetary Metals' Bold $38M Gold Bond: A Strategic Leap

A Golden Opportunity in Uncertain Times Monetary Metals just pulled a rabbit outta the hat with this $38 million gold bond. That’s tripling the size from their 2024 offering. Normally, I'm skeptical about flashy bond numbers, but there's a glint of genius here. In a world teetering on the brink of financial chaos, investors are itching for something solid. And gold?...

XPENG Eyes South Korea Entry with Industry Veteran

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Dodge Roars Back to NASCAR, Revving Up Stock Gains

When Dodge decides to hit the track running, they mean it. They're cranking the engines and returning to the NASCAR Cup Series after years in the shadows. This isn't just about going fast; it's about redefining speed on the stock car circuit and maybe even the market tickers. Revving an Old Engine for a New Race Let's get this out there: Dodge pulling a U-turn back into...